Movement Alert|Everpure Rises 3.02% in Regular Trading as Multiple Firms Lift Price Targets on AI Data Management Outlook

Market Focus
3 hours ago

On October 8, Everpure climbed 3.02% in regular trading, changing hands at $151.64 per share with turnover of $378 million. The advance followed a series of analyst target-price increases that reinforced confidence in the company's AI-driven data management growth trajectory.

Evercore ISI raised its price objective to $155 from $145 while maintaining an outperform rating, and Piper Sandler lifted its target to $162 from $133 with an overweight stance. The revisions reflect a more constructive view of Everpure's positioning in AI data software, scale-AI and hyperscale storage opportunities. UBS kept a sell rating and noted fiscal 2028 targets may already be partly reflected in the stock, even as it acknowledged strong growth supported by AI demand.

The company has guided to fiscal 2028 revenue of $7.0 billion to $7.3 billion with a non-GAAP operating margin of 24% to 26%, implying a two-year revenue compound annual growth rate of 38% to 41%, well above consensus estimates near 30%. This outlook has become a central pillar for the recent re-rating across sell-side models.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10